跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REVOLADE eltrombopag 50mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
REVOLADE eltrombopag 50mg film-coated tablet blister pack
Approved
STANDARD
REVOLADE eltrombopag 50mg film-coated tablet blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2fe12848fb580ab5
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2fe12848fb580ab5
Product Name
REVOLADE eltrombopag 50mg film-coated tablet blister pack
Artg Id
158356
Artg Name
REVOLADE eltrombopag 50mg film-coated tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2010-07-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/19e43810864b2c043f1b2f36020f7437.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/f51291b870ac09c1fb957f1b7f471d63.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2fe12848fb580ab5
Type
Standard
Back to TGA Approvals
